Company logo

BNGO - Bionano Genomics, Inc.

NASDAQ -> Healthcare -> Diagnostics & Research
San Diego, United States
Type: Equity

BNGO price evolution
BNGO
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $18.35 $34.97 $15.26 $4.5
Short term investments $83.94 $29.01 $62.21 $91.7
Net receivables $9.32 $8.67 $7.61 $6.78
Inventory $22.89 $26.43 $32.45 $33.11
Total current assets $140.12 $104.54 $122.58 $142.56
Long term investments
Property, plant & equipment $32.48 $30.99 $30.57 $29.77
Goodwill & intangible assets $33.97 $35.77 $114.84 $116.64
Total noncurrent assets $74.29 $77.37 $148.81 $149.59
Total investments $83.94 $29.01 $62.21 $91.7
Total assets $214.4 $181.9 $271.38 $292.15
Current liabilities
Accounts payable $10.38 $15.37 $11.91 $15.78
Deferred revenue $0.94 $0.96 $0.98 $1.13
Short long term debt $72.24 $2.46 $2.29 $2.52
Total current liabilities $100.03 $40.19 $33.5 $38.13
Long term debt $7.17 $7.68 $8.37 $8.65
Total noncurrent liabilities $18.22 $22.71 $23.13 $22.53
Total debt $79.41 $10.14 $10.66 $11.17
Total liabilities $118.25 $62.91 $56.63 $60.66
Shareholders' equity
Retained earnings -$581.21 -$537.32 -$424.75 -$385.84
Other shareholder equity $0.02 -$0.09 -$0.31 -$0.67
Total shareholder equity $96.16 $119 $214.76 $231.49
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $18.35 $5.49 $24.57 $38.45
Short term investments $83.94 $108.09 $226.04
Net receivables $9.32 $7.5 $4.93 $2.78
Inventory $22.89 $29.76 $12.39 $3.32
Total current assets $140.12 $157.3 $272.41 $46.79
Long term investments
Property, plant & equipment $32.48 $28.96 $20.93 $4.91
Goodwill & intangible assets $33.97 $118.43 $83 $8.65
Total noncurrent assets $74.29 $150.2 $104.69 $13.66
Total investments $83.94 $108.09 $226.04
Total assets $214.4 $307.5 $377.1 $60.45
Current liabilities
Accounts payable $10.38 $12.53 $9.7 $2.93
Deferred revenue $0.94 $0.87 $0.68 $0.42
Short long term debt $72.24 $2.54 $1.77
Total current liabilities $100.03 $35.88 $21.84 $8.94
Long term debt $7.17 $3.62 $8.93 $16.33
Total noncurrent liabilities $18.22 $22.22 $18.14 $16.42
Total debt $79.41 $11.67 $10.7 $16.33
Total liabilities $118.25 $58.1 $39.98 $25.37
Shareholders' equity
Retained earnings -$581.21 -$348.71 -$216.12 -$143.68
Other shareholder equity $0.02 -$1.12 -$0.54 $0
Total shareholder equity $96.16 $249.4 $337.12 $35.08
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $10.72 $9.32 $8.66 $7.42
Cost of revenue $8.28 $6.57 $6.35 $5.34
Gross Profit $2.44 $2.75 $2.31 $2.07
Operating activities
Research & development $11.7 $13.79 $14.61 $13.94
Selling, general & administrative $15.69 $24.9 $26.94 $25.98
Total operating expenses $23.94 $115.96 $41.55 $39.91
Operating income -$21.5 -$113.21 -$39.24 -$37.84
Income from continuing operations
EBIT -$39.03 -$112.46 -$38.8 -$37.02
Income tax expense -$0.04 $0.04 $0.03 $0.03
Interest expense $4.9 $0.07 $0.07 $0.08
Net income
Net income -$43.89 -$112.57 -$38.91 -$37.12
Income (for common shares) -$43.89 -$112.57 -$38.91 -$37.12
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $36.12 $27.8 $17.98 $8.5
Cost of revenue $26.55 $21.86 $14.11 $5.73
Gross Profit $9.57 $5.95 $3.87 $2.77
Operating activities
Research & development $54.03 $49.05 $22.48 $10.26
Selling, general & administrative $93.5 $88.6 $58.49 $31.07
Total operating expenses $221.36 $137.87 $81.03 $41.33
Operating income -$211.8 -$131.92 -$77.16 -$38.56
Income from continuing operations
EBIT -$227.31 -$130.41 -$77.22 -$38.56
Income tax expense $0.06 $1.88 -$5.72 $0.03
Interest expense $5.12 $0.3 $0.93 $2.52
Net income
Net income -$232.49 -$132.6 -$72.44 -$41.11
Income (for common shares) -$232.49 -$132.6 -$72.44 -$41.11
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$43.89 -$112.57 -$38.91 -$37.12
Operating activities
Depreciation $3.67 $3.69 $3.25 $3.35
Business acquisitions & disposals $0.1
Stock-based compensation $3.37 $3.99 $3.93 $3.88
Total cash flows from operations -$29.78 -$26.29 -$36.7 -$32.41
Investing activities
Capital expenditures -$0.74 -$0.07 -$0.51 -$0.36
Investments -$54.63 $33.5 $29.99 $16.89
Total cash flows from investing -$55.37 $33.43 $29.58 $16.53
Financing activities
Dividends paid
Sale and purchase of stock $11.02 $12.6 $17.89 $14.87
Net borrowings $66.47 -$0.01 -$0.01 -$0.01
Total cash flows from financing $68.48 $12.59 $17.88 $14.86
Effect of exchange rate $0.05 -$0.01 -$0.01 $0.04
Change in cash and equivalents -$16.62 $19.71 $10.75 -$0.99
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$232.49 -$132.6 -$72.44 -$41.11
Operating activities
Depreciation $13.97 $10.1 $4.04 $1.48
Business acquisitions & disposals $0.1 -$30.65 -$49.09 -$2.45
Stock-based compensation $15.18 $22.42 $9.72 $1.55
Total cash flows from operations -$125.18 -$124.82 -$71.93 -$38.31
Investing activities
Capital expenditures -$1.69 -$3.17 -$2.07
Investments $25.75 $116.69 -$226.91
Total cash flows from investing $24.16 $82.77 -$278.06 -$2.45
Financing activities
Dividends paid
Sale and purchase of stock $56.38 $23.04 $351.12 $66.63
Net borrowings $66.43 -$0.04 -$15.01 -$4.72
Total cash flows from financing $113.81 $23.01 $336.11 $61.9
Effect of exchange rate $0.07 -$0.04
Change in cash and equivalents $12.86 -$19.08 -$13.88 $21.14
Fundamentals
Market cap $49.87M
Enterprise value $110.93M
Shares outstanding 45.75M
Revenue $36.12M
EBITDA -$213.34M
EBIT -$227.31M
Net Income -$232.49M
Revenue Q/Q 30.51%
Revenue Y/Y 29.90%
P/E ratio -0.21
EV/Sales 3.07
EV/EBITDA -0.52
EV/EBIT -0.49
P/S ratio 1.38
P/B ratio 0.52
Book/Share 2.10
Cash/Share 0.40
EPS -$5.08
ROA -96.89%
ROE -140.61%
Debt/Equity 1.23
Net debt/EBITDA -0.47
Current ratio 1.40
Quick ratio 1.17